Bone Metastases
📧 Sign up to get email alerts when something new happens for Bone Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis，an Exploratory, Single-Arm, Multicenter Phase II Clinical Study [Phase 2]
An exploratory Phase II trial evaluating tislelizumab plus nab-paclitaxel as first-line treatment for advanced triple-negative breast cancer…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Skeletal Metastasis Registry
A clinical trial registry entry for a Skeletal Metastasis Registry sponsored by Johns Hopkins shows the study on metastatic bone tumors has …
-
CLINICAL_TRIALS withdrawal · 2024-10-01Clinical Trial Update: MR Guided Focused Ultrasound vs Radiotherapy for Palliative Pain Tx in Bone Metastases [NA]
Clinical trial comparing MR-guided focused ultrasound versus radiotherapy for palliative pain treatment in bone metastases was withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
This clinical trial update notes the termination of a study investigating the relationship between histamine and bone pain in participants w…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Validation of a Multitask Deep Learning System at Spine Metastasis CT
This completed trial validates a multitask deep learning system for CT imaging of spinal metastases.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2024-09-16EMA Authorised: Bondronat (ibandronic acid) — Atnahs Pharma Netherlands B.V.
EU marketing authorisation granted to Bondronat (ibandronic acid) for hypercalcemia, breast cancer with bone metastases, and bone-related fr…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Bipolar RFA of Painful Extra-spinal Bone Metastases [NA]
The trial evaluating bipolar radiofrequency ablation for painful extra-spinal bone metastases has been terminated.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases
This clinical trial update describes a study developing a dynamic prediction model for bone metastases in patients with breast cancer, spons…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients [Phase 2]
This document reports a Phase 2 clinical trial evaluating a luteinizing hormone-releasing hormone analogue in combination with enzalutamide,…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: MRI-guided Focused Ultrasound : Feasibility Study for the Treatment of Bone Metastases and osteoïd Osteoma [NA]
This document reports a feasibility study using MRI-guided focused ultrasound to treat painful bone metastases and superficial osteoid osteo…
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: Effectiveness and Safety of ArcBlate Palliative Treatment for Patients With Painful Bone Metastases: A Pivotal Study [NA]
This document outlines an ongoing pivotal clinical trial evaluating ArcBlate for effectiveness and safety in patients with painful bone meta…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases: An Extension Study [NA]
This Clinical Trial Update describes an extension study to assess the safety of ArcBlate MRgHIFU in patients with painful bone metastases; t…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: 18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery [NA]
A clinical trial evaluating 18F-FDG PET-MRI for planning and follow-up of spine tumors treated with spine stereotactic radiosurgery has comp…
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: [68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors [EARLY_Phase 1]
An early-phase PET/CT tracer [68Ga]Ga-P15-041 is being evaluated in patients with bone cancer and bone metastases in an initial study.
-
CLINICAL_TRIALS withdrawal · 2024-05-03Clinical Trial Update: MRI Guided HIFU for Palliation of Painful Skeletal Metastases in Children [NA]
An MRI-guided HIFU trial for palliation of pain from pediatric bone metastases has been withdrawn.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases
Clinical trial update on the efficacy and safety of Incadronate in breast cancer with bone metastases. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Palliation: the Effect of Education on Pain [Phase 3]
Phase 3 clinical trial evaluating whether education affects pain palliation in patients with bone metastases.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis [Phase 1, Phase 2]
A completed phase 1/2 study evaluating the feasibility of combining focused ultrasound with radiotherapy for painful bone metastases.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Efficacy of a Herbal Formula for Bone Metastases [Phase 1, Phase 2]
Early-phase clinical trial update evaluating a herbal formulation for bone metastases; current status and results are not provided.
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: BAY88-8223, Does Response Study in HRPC Patients [Phase 2]
Phase 2 clinical trial update for BAY88-8223 in hormone-refractory prostate cancer with bone metastases has completed.
-
FDA approval · 2023-03-08FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for zoledronic acid from Fresenius Kabi USA, LLC.
-
FDA approval · 2023-03-07FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for zoledronic acid submitted by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors [Phase 3]
Phase 3 trial assessing efficacy and safety of MW032 in combination with Xgeva for bone metastases from solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-22Clinical Trial Update: Biological Imaging Guided Antalgic Radiotherapy of Bone Metastases (Phase II Trial) [Phase 2]
Phase II clinical trial update on biologically guided antalgic radiotherapy for bone metastases.
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases [Phase 2, Phase 3]
Phase 2/3 trial update on image-guided stereotactic body radiotherapy for bone metastases.